MT Petrucci
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- Cytokine Signaling Pathways and Interactions
Papers in
- Hematology 15
- Multiple Myeloma Research and Treatments 14
- Oncology 8
- Cancer Treatment and Pharmacology 4
- Chemokine receptors and signaling 2
- Co-authors
- Ryan J. A. Chang (2 shared papers)Joshua Epstein (2 shared papers)Hironobu Hata (2 shared papers)J Woodliff (2 shared papers)Hong Xiao (2 shared papers)Meletios Α. Dimopoulos (5 shared papers)Martin Kropff (5 shared papers)Roman Hájek (2 shared papers)
- Journals
- Blood (3 papers)HemaSphere (2 papers)Journal of Clinical Oncology (2 papers)Haematologica (2 papers)Annals of Hematology (1 paper)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
MT Petrucci
13 papers receiving 296 citations
Peers
Comparison fields: 5 of 36
- Hematology 240
- Oncology 153
- Genetics 34
- Immunology and Allergy 17
- Molecular Biology 165
Countries citing papers authored by MT Petrucci
This map shows the geographic impact of MT Petrucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MT Petrucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MT Petrucci more than expected).
Fields of papers citing papers by MT Petrucci
This network shows the impact of papers produced by MT Petrucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MT Petrucci. The network helps show where MT Petrucci may publish in the future.
Co-authors
The 25 scholars most cited alongside MT Petrucci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 120 | |
| 2 | 2012 | 48 | |
| 3 | 1988 | 28 | |
| 4 | 1996 | 27 | |
| 5 | 2011 | 22 | |
| 6 | 2006 | 15 | |
| 7 | Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients. | 2000 | 14 |
| 8 | Prolonged therapy with bortezomib plus melphalan-prednisone (vmp) results in improved quality and duration of response in the phase iii vista study in previously untreated multiple myeloma (mm) | 2008 | 7 |
| 9 | 2021 | 7 | |
| 10 | 1993 | 6 | |
| 11 | 2019 | 2 | |
| 12 | 2009 | 2 | |
| 13 | 2009 | 1 | |
| 14 | Report of the European Myeloma Network (EMN) workshop on multiparametric flow cytometry in multiple myeloma and related disorders | 2007 | 0 |
| 15 | 2023 | 0 |
About MT Petrucci
MT Petrucci is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Immunology, having authored 15 papers that have together received 299 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (14 papers), Cancer Treatment and Pharmacology (4 papers), Chemokine receptors and signaling (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Glycosylation and Glycoproteins Research (2 papers), Protein Degradation and Inhibitors (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Hematology (240 citations), Oncology (153 citations), Genetics (34 citations), Immunology and Allergy (17 citations) and Molecular Biology (165 citations). MT Petrucci has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Ryan J. A. Chang, Joshua Epstein, Hironobu Hata, J Woodliff, Hong Xiao, Meletios Α. Dimopoulos, Martin Kropff, Roman Hájek, Philip Lewis and Annabel Nixon. Their work appears in journals such as Blood, HemaSphere, Journal of Clinical Oncology, Haematologica and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.